Cargando…

Low population serum microneutralization antibody titer against the predominating influenza A(H3N2) N121K virus during the severe influenza summer peak of Hong Kong in 2017

The 2017 Hong Kong influenza A(H3N2) summer season was unexpectedly severe. However, antigenic characterization of the 2017 circulating A(H3N2) viruses using ferret antisera did not show significant antigenic drift. We analyzed the hemagglutinin amino acid sequences of A(H3N2) virus circulating in H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Houshun, Lee, Andrew C. Y., Li, Can, Mak, Winger W. N., Chen, Yetta Y., Chan, Kwok-Hung, Zhang, Anna J. X., Fung, Wai-Fong, Zhang, Rui-Qi, Fung, Yim-Fong, Poon, Rosana W. S., Lam, Joy-Yan, Tam, Sidney, Hung, Ivan F. N., Chen, Honglin, Yuen, Kwok-Yung, To, Kelvin K. W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841213/ https://www.ncbi.nlm.nih.gov/pubmed/29511175 http://dx.doi.org/10.1038/s41426-018-0041-1

Ejemplares similares

H7N9 influenza A virus activation of necroptosis in human monocytes links innate and adaptive immune responses
por: Lee, Andrew C. Y., et al.
Publicado: (2019)

Comparability of Titers of Antibodies against Seasonal Influenza Virus Strains as Determined by Hemagglutination Inhibition and Microneutralization Assays
por: Heeringa, Marten, et al.
Publicado: (2020)

Co-stimulation With TLR7 Agonist Imiquimod and Inactivated Influenza Virus Particles Promotes Mouse B Cell Activation, Differentiation, and Accelerated Antigen Specific Antibody Production
por: Li, Can, et al.
Publicado: (2018)

Corrigendum: Co-stimulation with TLR7 agonist imiquimod and inactivated Influenza virus particles promotes mouse B cell activation, differentiation, and accelerated antigen specific antibody production
por: Li, Can, et al.
Publicado: (2022)

An In Vitro Microneutralization Assay for Influenza Virus Serology
por: Cuevas, Frans, et al.
Publicado: (2022)

Influence of sample collection tube method, anticoagulant-containing plasma versus serum, on influenza virus hemagglutination inhibition titer and microneutralization titer serological assays
por: Morrison, Brian J., et al.
Publicado: (2018)

Rapid Detection of Reassortment of Pandemic H1N1/2009 Influenza Virus
por: Poon, Leo L M, et al.
Publicado: (2010)

Rate of decline of antibody titers to pandemic influenza A (H1N1-2009) by hemagglutination inhibition and virus microneutralization assays in a cohort of seroconverting adults in Singapore
por: Hsu, Jung Pu, et al.
Publicado: (2014)

Oseltamivir-Resistant Influenza A Pandemic (H1N1) 2009 Virus, Hong Kong, China
por: Chen, Honglin, et al.
Publicado: (2009)

Avian Influenza A H7N9 Virus Induces Severe Pneumonia in Mice without Prior Adaptation and Responds to a Combination of Zanamivir and COX-2 Inhibitor
por: Li, Can, et al.
Publicado: (2014)

Clinical and Virological Factors Associated with Viremia in Pandemic Influenza A/H1N1/2009 Virus Infection
por: Tse, Herman, et al.
Publicado: (2011)

Microneutralization Assay Titres Correlate with Protection against Seasonal Influenza H1N1 and H3N2 in Children
por: Verschoor, Chris P., et al.
Publicado: (2015)

Evaluation of immunogenicity of the 2008-2009 seasonal influenza vaccines by microneutralization test
por: Kim, Seung Youn, et al.
Publicado: (2012)

A rapid and flexible microneutralization assay for serological assessment of influenza viruses
por: Rumfelt, Kalee E., et al.
Publicado: (2023)

Loop-Mediated Isothermal Amplification for Influenza A (H5N1) Virus
por: Jayawardena, Shanthi, et al.
Publicado: (2007)

Correction: Microneutralization Assay Titres Correlate with Protection against Seasonal Influenza H1N1 and H3N2 in Children
por: Verschoor, Chris P., et al.
Publicado: (2016)

Correlation between Commercial Anti-RBD IgG Titer and Neutralization Titer against SARS-CoV-2 Beta Variant
por: Poon, Rosana Wing-Shan, et al.
Publicado: (2021)

International Laboratory Comparison of Influenza Microneutralization Assays for A(H1N1)pdm09, A(H3N2), and A(H5N1) Influenza Viruses by CONSISE
por: Laurie, Karen L., et al.
Publicado: (2015)

Rapid Genotyping of Swine Influenza Viruses
por: Mak, Polly W.Y., et al.
Publicado: (2011)

Immunogenicity and safety of influenza vaccination in patients with juvenile idiopathic arthritis on biological therapy using the microneutralization assay
por: Camacho-Lovillo, M. S., et al.
Publicado: (2017)

Assessment of population susceptibility to upcoming seasonal influenza epidemic strain using interepidemic emerging influenza virus strains
por: Chen, Lin-Lei, et al.
Publicado: (2019)

Microneutralization assay titer correlates analysis in two phase 3 trials of the CYD-TDV tetravalent dengue vaccine in Asia and Latin America
por: Carpp, Lindsay N., et al.
Publicado: (2020)

The emergence of influenza A H7N9 in human beings 16 years after influenza A H5N1: a tale of two cities
por: To, Kelvin KW, et al.
Publicado: (2013)

Influenza A(H1N1)pdm09 Virus Infection in a Captive Giant Panda, Hong Kong
por: Martelli, Paolo, et al.
Publicado: (2019)

The Natural Viral Load Profile of Patients With Pandemic 2009 Influenza A(H1N1) and the Effect of Oseltamivir Treatment
por: Li, Iris W., et al.
Publicado: (2010)

Age- Matched Comparison of Children Hospitalized for 2009 Pandemic H1N1 Influenza with Those Hospitalized for Seasonal H1N1 and H3N2
por: Chiu, Susan S., et al.
Publicado: (2011)

Single radial haemolysis compared to haemagglutinin inhibition and microneutralization as a correlate of protection against influenza A H3N2 in children and adolescents
por: Wang, Biao, et al.
Publicado: (2017)

Wild Type and Mutant 2009 Pandemic Influenza A (H1N1) Viruses Cause More Severe Disease and Higher Mortality in Pregnant BALB/c Mice
por: Chan, Kwok-Hung, et al.
Publicado: (2010)

The Comparison of Sensitivity and Specificity of ELISA-based Microneutralization Test with Hemagglutination Inhibition Test to Evaluate Neutralizing Antibody against Influenza Virus (H1N1)
por: TAVAKOLI, Ahmad, et al.
Publicado: (2017)

SMRT sequencing revealed the diversity and characteristics of defective interfering RNAs in influenza A (H7N9) virus infection
por: Lui, Wing-Yu, et al.
Publicado: (2019)

The Therapeutic Effect of Pamidronate on Lethal Avian Influenza A H7N9 Virus Infected Humanized Mice
por: Zheng, Jian, et al.
Publicado: (2015)

Unique reassortant of influenza A(H7N9) virus associated with severe disease emerging in Hong Kong
por: To, Kelvin Kai-Wang, et al.
Publicado: (2014)

HAI and NAI titer correlates of inactivated and live attenuated influenza vaccine efficacy
por: Gilbert, Peter B, et al.
Publicado: (2019)

Knowledge, risk perceptions, and preventive precautions among Hong Kong students during the 2009 influenza A (H1N1) pandemic
por: Mak, Kwok-Kei, et al.
Publicado: (2012)

Complete Genome Sequence of Influenza Virus H9N2 Associated with a Fatal Outbreak among Chickens in Dubai
por: Lau, Siu-Ying, et al.
Publicado: (2016)

A neuraminidase activity-based microneutralization assay for evaluating antibody responses to influenza H5 and H7 vaccines
por: Zhao, Hui, et al.
Publicado: (2018)

Repurposing of Miltefosine as an Adjuvant for Influenza Vaccine
por: Lu, Lu, et al.
Publicado: (2020)

Systemic infection of avian influenza A virus H5N1 subtype in humans()
por: Zhang, Zengfeng, et al.
Publicado: (2009)

Pathogenesis of pandemic H1N1 2009 influenza virus infection and the implication on management
por: To, Kelvin Kai-Wang, et al.
Publicado: (2010)

Avian influenza A H5N1 virus: a continuous threat to humans
por: To, Kelvin KW, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_f2h0rc56r1oscbkskdvs29q1tt